Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Deep Vein Thrombosis
Perform Another (Advanced) Search
53 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (713) Trial #156537, Thrombosis, Charlottesville, VA ...Information Men and Women age 18 or older with active malignancy and a newly diagnosed deep-vein thrombosis UVa Health System, Department of Hematology-Oncology; Hematology Division, seeks Men and Women ages ...View Page
2. Study Posting (1570) Trial #156497, Thrombosis, Morristown, NJ ...Thrombosis, Morristown, NJ Trial Information Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism The purpose of this study is to evaluate the effects of ...View Page
3. Study Posting (5359) Trial #155052, Thrombosis, West Reading, PA ...Reading, PA Trial Information Have you or someone you know been recently diagnosed with a Deep Vein Thrombosis (DVT). If so, please contact Crystal Nagle at 610-988-4308 and see if ...View Page
4. CenterWatch: Clinical Trials in Category (147) Thrombosis ...Jersey Morristown : Atlantic Health System Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Morristown : Atlantic Health System Study of Apixaban for the Prevention of ...View Page
5. Newly Approved Drug Therapies (259) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, ...Lovenox (enoxaparin sodium) Injection Company: Rhone Poulenc Rorer Approval Status: Approved May 1997 Treatment Area: deep vein thrombosis General Information Lovenox (enoxaparin sodium) Injection has been approved for use in the prevention ...View Page
6. Newly Approved Drug Therapies (748) Arixtra, Organon, Sanofi-Synthelabo, ...presentations. Drug Name: Arixtra Company: Organon, Sanofi-Synthelabo Approval Status: Approved December 2001 Treatment Area: Deep vein thrombosis prophylaxis General Information Arixtra, an injectable solution for subcutaneous use, has been approved as ...View Page
7. Newly Approved Drug Therapies (639) Innohep (tinzaparin sodium) injectable, DuPont Merck Pharmaceutical Company, ...tinzaparin sodium) injectable Company: DuPont Merck Pharmaceutical Company Approval Status: Approved July 2000 Treatment Area: Deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium General Information ...View Page
8. Study Posting (1570) Trial #156500, Thrombosis, Morristown, NJ ...of this study is to learn if apixaban can prevent blood clots in the leg (deep vein thrombosis [DVT]) and lung (pulmonary embolism [PE]) that sometimes occur within patients hospitalized for acute ...View Page
9. Study Posting (713) Trial #150276, Blood Clots, Charlottesville, VA ...seeks people over age 18 who have experienced a blood clot (also known as a deep vein thrombosis or pulmonary embolism) in the past 12 months and are currently taking blood thinner ...View Page
10. Newly Approved Drug Therapies (535) Fragmin, Pharmacia & Upjohn, ...Approved March 1999 Treatment Area: Hematology General Information FRAGMIN Injection is indicated for prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism: • In patients undergoing hip replacement surgery • In ...View Page
11. Newly Approved Drug Therapies (551) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, ...Information Lovenox has been approved for the following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2 ...View Page
12. CenterWatch: New Medical Therapies in Disease Category (147), Thrombosis ...30 mg given twice daily. The primary efficacy outcome, a composite of symptomatic or asymptomatic deep vein thrombosis, pulmonary embolism, and death by any cause, was not reached. The rate of the ...View Page
13. CenterWatch: Hematology Approved Drug Therapies ...2002 Drugs Approved in 2001 Arixtra ; Organon, Sanofi-Synthelabo; Injectable solution for the prevention of deep vein thrombosis, Approved December 2001 Drugs Approved in 2000 Argatroban Injection ; Texas Biotechnology Corporation, SmithKline Beecham ...View Page
14. Newly Approved Drug Therapies (401) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, ...surgery General Information Lovenox (enoxaparin sodium) Injection has been approved for the extended prevention of deep-vein thrombosis (DVT) following hip replacement surgery. It was previously approved for use in a hospital ...View Page
15. CenterWatch: New Medical Therapies in Disease Category (315), Hip Replacement ...trial of Exanta (ximelagatran) versus enoxaparin, a low-molecular-weight heparin for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Data showed Exanta significantly reduced the risk of proximal ...View Page
16. CenterWatch: List of Newly Approved Drug Thearapies ...2000 Innohep (tinzaparin sodium) injectable ; DuPont Merck Pharmaceutical Company; For the treatment of acute symptomatic deep vein thrombosis, Approved July 2000 Lescol XL (fluvastatin sodium) tablet, extended release ; Novartis; For the use ...View Page
17. Study Posting (2917) Trial #154937, Colon Cancer, Beech Grove, IN ...anticancer therapy for treatment of metastatic colorectal carcinoma • Clinically significant cardiac disease • Recent pulmonary embolism, deep vein thrombosis, or other significant venous event Cathy Spears, Research Manager St. Francis Hospital and Health ...View Page
18. CenterWatch: New Medical Therapies in Disease Category (316), Knee Replacement ...30 mg given twice daily. The primary efficacy outcome, a composite of symptomatic or asymptomatic deep vein thrombosis, pulmonary embolism, and death by any cause, was not reached. The rate of the ...View Page
19. CenterWatch: List of Newly Approved Drug Thearapies ...treatment of iron deficiency anemia., Approved February 1999 Fragmin ; Pharmacia & Upjohn; Treatment of prophylaxis of deep vein thrombosis (DVT), Approved March 1999 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for acute ...View Page
20. CenterWatch Clinical Research Profile (2338) Trial #1132, The William W. Backus Hospital, Norwich, CT ...cardiology, HIV and psychiatry for the last 15 years. Other projects have included registries of Deep Vein Thrombosis, Acute Coronary Syndrome, and Congestive Heart Failure; studies on gene expression of human joint ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.